Mount Sinai
Mount Sinai Health Launches Center for Undiagnosed Diseases With $3.3M NIH Grant
Besides making diagnoses, the newest center in the NIH Undiagnosed Diseases Network plans to undertake "research-based characterization" of patients with immunological disorders.
New York State Awards $3M to Researchers for Infectious Disease Tool Innovations
Teams from Rover Diagnostics, Mount Sinai, Columbia University, and Niagara University are the third round of awardees of the state’s Biodefense Commercialization Fund.
HPV Tumor DNA Liquid Biopsy Test Shows Promise for Oropharyngeal Cancer Diagnosis, Surveillance
Researchers studied the accuracy of a commercial HPV tumor DNA blood test in almost 400 patients with HPV-related oropharyngeal squamous cell carcinoma.
Linus Biotechnology Raises $16M in Series A Funding
The Mount Sinai spinout will use the funds to advance its StrandDx platform, correlating environmental exposures to biological responses.
Gene Signature Reflects Host Response to COVID-19 Infections With Low Cross-Reactivity
The researchers established a framework to generate robust host infection response signatures with the aim of improving diagnostic sensitivity.